China News Service, December 19th. According to multiple US media reports, on the evening of the 18th local time, the US Food and Drug Administration (FDA) has authorized Moderna's new crown vaccine to be used urgently in the United States.
It is reported that the vaccine was developed by Moderna Biotech in the United States in collaboration with the National Institute of Allergy and Infectious Diseases, which is very similar to the Pfizer new crown vaccine that was previously approved by the FDA. The vaccine has also become the second COVID-19 vaccine approved by U.S. regulators.
On December 14, local time, a nurse in Long Island Jewish Medical Center in New York was preparing to get the COVID-19 vaccine. On the same day, the first batch of nearly 3 million doses of the new crown vaccine of Pfizer arrived in various parts of the United States one after another. Photo by Liao Pan, China News Service reporter
FDA said, "The emergency use authorization allows the vaccine to be distributed in the United States for people aged 18 and above."
Professor and chair of the Department of Tropical Medicine at Baylor College of Medicine in the United States, said: "This is an exciting moment, but it is also a heartbreaking moment." Currently, the number of confirmed cases of new crown in the United States has exceeded 17.41 million, and deaths exceeds 313,000, and the number of confirmed, hospitalized and deaths is still rising.
The United States began COVID-19 vaccination on December 14, and the first batch of vaccinated people were medical staff and groups living in long-term care institutions such as nursing homes. Recently, a medical staff member in Alaska, USA, developed severe allergic reactions such as shortness of breath after receiving the Pfizer COVID-19 vaccine.
Source: China News Network
